Chemoinformaics analysis of 2-(2,2-Dimethylhydrazino)-4-(5-nitro-2-furyl)thiazole
| Molecular Weight | 254.271 | nRot | 4 |
| Heavy Atom Molecular Weight | 244.191 | nRig | 6 |
| Exact Molecular Weight | 254.047 | nRing | 2 |
| Solubility: LogS | -3.927 | nHRing | 2 |
| Solubility: LogP | 3.764 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 7 | APOL | 31.4039 |
| nHD | 1 | BPOL | 17.6741 |
| QED | 0.586 |
| Synth | 2.453 |
| Natural Product Likeliness | 1.484 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.827 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.552 |
| MDCK | 0.0000202 |
| BBB | 0.699 |
| PPB | 0.9201 |
| VDSS | 0.663 |
| FU | 0.109569 |
| CYP1A2-inh | 0.909 |
| CYP1A2-sub | 0.938 |
| CYP2c19-inh | 0.714 |
| CYP2c19-sub | 0.56 |
| CYP2c9-inh | 0.379 |
| CYP2c9-sub | 0.668 |
| CYP2d6-inh | 0.599 |
| CYP2d6-sub | 0.336 |
| CYP3a4-inh | 0.072 |
| CYP3a4-sub | 0.27 |
| CL | 6.049 |
| T12 | 0.572 |
| hERG | 0.019 |
| Ames | 0.028 |
| ROA | 0.316 |
| SkinSen | 0.632 |
| Carcinogencity | 0.438 |
| EI | 0.961 |
| Respiratory | 0.864 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.749821 |